Genprex Inc. (NASDAQ: GNPX) Obtains New License for Novel Diabetes Gene Therapy Pipeline
U.S.-based gene therapy developer Genprex, Inc. is developing new therapies for fighting cancer tumors and diabetes The company’s gene therapies…
U.S.-based gene therapy developer Genprex, Inc. is developing new therapies for fighting cancer tumors and diabetes The company’s gene therapies…
Ucore Rare Metals Inc. is demonstrating the rare earth feedstock refining capabilities of its proprietary RapidSX(TM) processing technology at an…
Reflex (CSE: RFLX) (OTCQB: RFLXF) (FWB: HF2) is advancing its flagship Ruby Graphite Project in Beaverhead County in southwestern Montana.…
BiondVax (NASDAQ: BVXV), a biotechnology company that recently signed an exclusive worldwide license to develop and commercialize innovative alpaca-derived nanosized…
Prospera (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B), a public oil and gas exploration, exploitation, and development company focusing on conventional…
GolfLync, the company behind the GolfLync app – a social network for matching golf games and players, previously announced the…
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, recently…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced a…
Mullen Automotive’s (NASDAQ: MULN) CEO and Chairman David Michery appeared on “Making Money with Charles Payne” on Fox Business on…
Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is in the spotlight. Cepton CEO and cofounder…